RE: [GreenYes] Clopyralid and Compost (Dow ArgoSciences)

["Spivey, Susie" <SSpivey@beerscc.com>]

Fear not...I don't do free advertising. I don't support the product either.
Actually a friend forwarded it to me, I passed it on to you all simply for
knowledge. THAT'S IT. The message was written by DOW and simply forwarded by
me. 

-----Original Message-----
From: Chris Sparnicht [mailto:chris@grrn.org]
Sent: Monday, October 22, 2001 10:21 AM
To: GreenYes
Subject: Re: [GreenYes] Clopyralid and Compost (Dow ArgoSciences)


Susie,

It seems you may have some opinions on Dow's clopyralid based
product 'Confront.' In the document you cut and pasted from
a clopyralid advertisement into greenyes for our list, 
I don't see any evidence of what it may be. I can only infer
that you use Confront on a regular basis and that you want
others to know about it. That's advertisement.
Please clarify with either an opinion or question if you have one.

Also as a note to all members, please allow me to let this
serve as a reminder that commercial advertisement is not
allowed on this list. The only allowed advertisement is for 
recycling/zero waste job postings and for 
recycling/ecological/zero waste events.

Unless there are objections, this advertisement will 
be deleted from our greenyes archive at the month's end.

Regards,

Chris Sparnicht



----- Original Message ----- 
From: "Spivey, Susie" <SSpivey@beerscc.com>
To: "GreenYes" <greenyes@grrn.org>
Sent: Friday, October 19, 2001 4:26 PM
Subject: [GreenYes] Clopyralid and Compost (Dow ArgoSciences)


> Clopyralid and Compost
> 
[snip]

******************************************
To post to the greenyes list,
email to: greenyes@grrn.org

Subscription information for
this list is available here:
http://www.grrn.org/general/greenyes.html
******************************************
******************************************
To post to the greenyes list,
email to: greenyes@grrn.org

Subscription information for
this list is available here:
http://www.grrn.org/general/greenyes.html
******************************************